Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 04, 2021
Source ID
10.1007/s10552-021-01485-3

Entities

People

  • Charles L. Wiggins
  • Christopher I. Li
  • Deirdre A. Hill
  • Linda S. Cook
  • Mei-tzu C. Tang
  • Nicole C Lorona

Organizations

  • National Cancer Institute
  • United States Department of Defense